Apoptotic Janus-faced mycotoxins against thoracal and breast metastases

Gaspar Banfalvi1

  • 1Department of Molecular Biotechnology and Microbiology and Department of Physiology, University of Debrecen, 1 Egyetem Square, Life Sciences Building 1.102, Debrecen, 4010, Hungary. banfalvi.gaspar@science.unideb.hu.

Insights

This study reveals abdominal tumors can metastasize to the breast, challenging the traditional view. Researchers used rodent models to track tumor cell spread to parathymic lymph nodes, suggesting new therapeutic targets.

Area of Science:

  • Oncology
  • Cancer Metastasis Research

Background:

  • Abdominal organs (liver, kidney, spleen) are common sites for cancer invasion, but their primary tumors rarely metastasize to distant sites like the breast.
  • The metastatic pathway from breast cancer to the liver is well-documented, yet the reverse pathway, from abdominal tumors to the breast, remains understudied.

Purpose of the Study:

  • To investigate the metastatic potential of primary abdominal tumors to the breast.
  • To elucidate the migratory pathway of abdominal tumor cells to distant sites, specifically focusing on lymph node involvement.

Main Methods:

  • Utilized rodent tumor models by implanting tumor cells under the kidney or liver capsule.
  • Tracked tumor cell migration using injected colloidal carbon particles to mimic tumor cell dissemination.
  • Examined the role of parathymic lymph nodes (PTNs) in the metastatic process.

Main Results:

  • Tumor cells implanted in abdominal organs successfully formed primary tumors.
  • Tumor cells disseminated via abdominal cavity, diaphragm apertures, and thoracic lymphatics, accumulating in parathymic lymph nodes (PTNs).
  • Colloidal carbon particles demonstrated a similar migration pattern to PTNs, validating the observed tumor cell pathway.

Conclusions:

  • Abdominal primary tumors possess the capability to metastasize to the breast, contrary to previous assumptions.
  • Parathymic lymph nodes (termed internal mammary or parasternal nodes in humans) are critical in the metastatic spread from abdominal tumors.
  • Janus-faced cytotoxins inducing apoptosis present a potential therapeutic strategy against abdominal tumor metastasis.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K